Cargando…

Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT

OBJECTIVES: The management of incidental findings of FDG‐avid tonsils on PET/CT (IFT) is unclear. We aimed to explore the prevalence of malignancy in IFT, identify risk factors for malignancy, and calculate optimal cutoffs of maximum standardized uptake values (SUV(max)) to discriminate between beni...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinholdt, Kasper Basse, Dias, André Henrique, Hoff, Camilla Molich, Gormsen, Lars Christian, Klug, Tejs Ehlers
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790499/
https://www.ncbi.nlm.nih.gov/pubmed/35226376
http://dx.doi.org/10.1002/lary.30081
_version_ 1784859190629498880
author Reinholdt, Kasper Basse
Dias, André Henrique
Hoff, Camilla Molich
Gormsen, Lars Christian
Klug, Tejs Ehlers
author_facet Reinholdt, Kasper Basse
Dias, André Henrique
Hoff, Camilla Molich
Gormsen, Lars Christian
Klug, Tejs Ehlers
author_sort Reinholdt, Kasper Basse
collection PubMed
description OBJECTIVES: The management of incidental findings of FDG‐avid tonsils on PET/CT (IFT) is unclear. We aimed to explore the prevalence of malignancy in IFT, identify risk factors for malignancy, and calculate optimal cutoffs of maximum standardized uptake values (SUV(max)) to discriminate between benign and malignant lesions. METHODS: All patients who were tonsillectomized at our institution because of IFT from October 2011 to December 2020 were included. Patients undergoing PET/CT due to suspected tonsillar disease or cancer of unknown primary were excluded. RESULTS: In total, 77 patients were included, of which 11 (14%) of them had IFT malignancy. Dysphagia (p = 0.019) and alcohol abuse (p = 0.035) were associated with malignancy. Absolute SUV(max) cutoff (≥9: sensitivity 100%; specificity 53%) was superior to SUV(max) side‐to‐side ratio (≥1.5: sensitivity 64%; specificity 70%) to discriminate between benign and malignant lesions. CONCLUSION: We recommend tonsillectomy for patients with IFT displaying SUV(max) ≥ 9.0, ratio ≥ 1.5, or symptoms or findings suggesting malignancy. LEVEL OF EVIDENCE: 3 Laryngoscope, 132:2370–2378, 2022
format Online
Article
Text
id pubmed-9790499
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-97904992022-12-28 Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT Reinholdt, Kasper Basse Dias, André Henrique Hoff, Camilla Molich Gormsen, Lars Christian Klug, Tejs Ehlers Laryngoscope Head and Neck OBJECTIVES: The management of incidental findings of FDG‐avid tonsils on PET/CT (IFT) is unclear. We aimed to explore the prevalence of malignancy in IFT, identify risk factors for malignancy, and calculate optimal cutoffs of maximum standardized uptake values (SUV(max)) to discriminate between benign and malignant lesions. METHODS: All patients who were tonsillectomized at our institution because of IFT from October 2011 to December 2020 were included. Patients undergoing PET/CT due to suspected tonsillar disease or cancer of unknown primary were excluded. RESULTS: In total, 77 patients were included, of which 11 (14%) of them had IFT malignancy. Dysphagia (p = 0.019) and alcohol abuse (p = 0.035) were associated with malignancy. Absolute SUV(max) cutoff (≥9: sensitivity 100%; specificity 53%) was superior to SUV(max) side‐to‐side ratio (≥1.5: sensitivity 64%; specificity 70%) to discriminate between benign and malignant lesions. CONCLUSION: We recommend tonsillectomy for patients with IFT displaying SUV(max) ≥ 9.0, ratio ≥ 1.5, or symptoms or findings suggesting malignancy. LEVEL OF EVIDENCE: 3 Laryngoscope, 132:2370–2378, 2022 John Wiley & Sons, Inc. 2022-02-28 2022-12 /pmc/articles/PMC9790499/ /pubmed/35226376 http://dx.doi.org/10.1002/lary.30081 Text en © 2022 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Head and Neck
Reinholdt, Kasper Basse
Dias, André Henrique
Hoff, Camilla Molich
Gormsen, Lars Christian
Klug, Tejs Ehlers
Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
title Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
title_full Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
title_fullStr Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
title_full_unstemmed Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
title_short Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
title_sort incidental fdg‐avid focuses in palatine tonsils on pet/ct
topic Head and Neck
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790499/
https://www.ncbi.nlm.nih.gov/pubmed/35226376
http://dx.doi.org/10.1002/lary.30081
work_keys_str_mv AT reinholdtkasperbasse incidentalfdgavidfocusesinpalatinetonsilsonpetct
AT diasandrehenrique incidentalfdgavidfocusesinpalatinetonsilsonpetct
AT hoffcamillamolich incidentalfdgavidfocusesinpalatinetonsilsonpetct
AT gormsenlarschristian incidentalfdgavidfocusesinpalatinetonsilsonpetct
AT klugtejsehlers incidentalfdgavidfocusesinpalatinetonsilsonpetct